Day: Tubules

Munich-based biotech unicorn Tubulis is being sold to US corporation Gilead for a billion-dollar sum.

Saskia Doll April 10, 2026

Munich remains a unicorn hotspot: Based on a recent analysis of our Munich Startup Insights, we show you which startups have broken the billion-dollar valuation mark…

Saskia Doll February 5, 2026

Munich-based biotech company Tubulis has increased its Series C financing round from €308 million to €344 million, thereby accelerating its development…

Saskia Doll November 3, 2025

Munich-based biotech Tubulis is working on special antibody drug conjugates (ADCs) for cancer therapy. The company has now secured €308 million in funding…

Saskia Doll October 17, 2025

Three Munich startups impressed at this year's European Lifestars Awards in London: Of all the applications and nominees received…

Regina Bruckschlögl December 14, 2024

Tubulis is working on special antibody-drug conjugates for cancer therapy. The Munich-based biotech company has now completed an expanded and oversubscribed Series B2 financing round totaling…

Saskia Doll March 19, 2024

Tubulis has entered into a strategic partnership with the American pharmaceutical company Bristol Myers Squibb. The startup, based at the IZB in…

Simon Tischer April 24, 2023

Munich is one of Germany's leading biotech hubs. Research is conducted here on a wide variety of medications and therapies, including cancer. We…

Maximilian Feigl February 21, 2023

Tubulis secures €60 million ($63 million) in its Series B funding. The round is led by Andera Partners.…

Simon Tischer May 11, 2022

The series of investments for health and biotech startups continues: Now the biotech company Tubulis announced a Series A financing worth millions.

Helen Duran July 24, 2020